TrialClinical pharmacology in drug development2021

Population Pharmacokinetic Analysis of BMS-986166, a Novel Selective Sphingosine-1-Phosphate-1 Receptor Modulator, and Exposure-Response Assessment of Lymphocyte Counts and Heart Rate in Healthy Participants.

Sébastien Bihorel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.